LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported a loss of $37.7 million in its first quarter.

The Lexington, Massachusetts-based company said it had a loss of $1.03 per share. Losses, adjusted for non-recurring costs, were $1 per share.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 93 cents per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNCE at https://www.zacks.com/ap/CNCE

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News